Gocovri is indicated for the treatment of dyskinesia in patients with Parkinson's disease who are experiencing motor fluctuations [1].
What is the recommended dosage for Gocovri?
The recommended dosage for Gocovri is one 670 mg extended-release capsule taken orally once daily at bedtime [1]. Patients should not take Gocovri with the evening meal [1].
What are the different strengths of Gocovri?
Gocovri is available in a single strength of 670 mg [1].
Can Gocovri dosage be adjusted?
The prescribing information for Gocovri does not detail dosage adjustments. It is a once-daily, fixed-dose medication [1].
How is Gocovri administered?
Gocovri is an extended-release capsule taken by mouth once a day at bedtime [1]. It is important for patients to take it consistently at the same time each day [1].
What should I do if I miss a dose of Gocovri?
If a dose of Gocovri is missed, patients should take the next dose at their usual bedtime [1]. They should not take a double dose to make up for a missed dose [1].
When does Gocovri patent exclusivity expire?
Information regarding Gocovri's patent exclusivity expiration can be found on DrugPatentWatch.com [2]. Details on patent timelines are crucial for understanding potential market entry for generic or biosimilar versions of the drug [2].
Who manufactures Gocovri?
Gocovri is manufactured by Adamas Pharmaceuticals, Inc [1].
Are there any warnings or precautions for Gocovri?
Gocovri has specific warnings and precautions, including potential risks such as hallucinations and psychotic behaviors, somnolence and sudden onset of sleep, and peripheral edema [1]. Patients with a history of these conditions should discuss them with their healthcare provider before starting Gocovri [1].
What are the common side effects of Gocovri?
Common side effects reported in clinical trials for Gocovri include hallucinations, confusion, and dizziness [1].
How does Gocovri work?
Gocovri is believed to work by modulating dopamine neurotransmission, which is implicated in Parkinson's disease [1].
What is Gocovri used for?
Gocovri is used to treat dyskinesia in patients with Parkinson's disease who experience motor fluctuations [1].
Are there alternative treatments for dyskinesia in Parkinson's disease?
Alternative treatments for dyskinesia in Parkinson's disease may include other medications or adjustments to existing Parkinson's therapies. Consulting a healthcare professional is essential for personalized treatment plans [3].
Sources:
[1] Gocovri Prescribing Information
[2] https://www.drugpatentwatch.com/
[3] National Institute of Neurological Disorders and Stroke